Displaying 41-60 of 60 results for

On March 13, 2020, ASTHO CEO Michael Fraser released a statement applauding President Trump's emergency declaration.

“Building Bridges to Better Health,” the theme for the 2021 National Public Health Week. ASTHO is committed to building and maintaining the partnerships and connections needed to achieve our shared vision of state and territorial health ...

This week has been both exhilarating and poignant. Almost surreal. We started the week by pausing to celebrate and reflect on the life and legacy of one of America’s greatest sons, Dr. Martin Luther King, Jr. On Tuesday, ASTHO participated ...

On May 6, 2021, ASTHO and the de Beaumont Foundation and have released a short vaccine communication guide to help physicians build confidence in the vaccines. The guide's techniques are based on recent polling and focus groups that ...

Metadescription here

On Dec. 14, 2021, ASTHO CEO Michael Fraser released a statement with Claire Hannan and Brent Ewig, reflecting on the year since the first COVID-19 vaccine was administered.

On Dec. 10, 2020, ASTHO president and Pennsylvania secretary of health Rachel Levine, MD, testified about the COVID-19 vaccine before a Senate subcommittee.

As July 4, 2020 approaches, physicians and health officials across the country are urging Americans to practice social distancing, wear masks, and generally remember to follow COVID-safe procedures to help stem the spread of the virus.

On April 3, 2020, ASTHO CEO Michael Fraser issued a statement emphasizing the importance of using face coverings as a potential intervention to slow the spread of the COVID-19 virus.

On March 10, 2023, ASTHO announced that several organization experts, including ASTHO staff, leadership, and former state health officials, are featured in the March issue of Health Affairs, which is focused on public health lessons during ...

On Feb. 24, 2021, ASTHO member and public health leader Ngozi Ezike, MD, director of the Illinois Department of Public Health, testified before the House Homeland Security Committee. Ezike answered questions in the hearing, ...

On Feb. 24, 2020, ASTHO, as part of a coalition of public health organizations, issued a request that the administration propose, and Congress pass, an FY 2020 supplemental appropriations bill to expand and capacity and coordination to ...

On March 27, 2020, ASTHO CEO Michael Fraser issued a statement warning against prematurely lifting or easing the public health measures aimed at reducing the risk of COVID-19 transmissions.

On Jan. 21, 2020, Nathaniel Smith, MD, MPH, secretary of health at the Arkansas Department of Health and ASTHO president, issued a statement acknowledging the first confirmed case of COVID-19 in the U.S. Smith assured the public that ...

On Oct. 20, 2020, ASTHO and the American Pharmacists Association announced the formation of the National Associations' COVID Vaccine Leadership Council. A coalition dedicated to the creation of a safe and efficient COVID-19 vaccine ...

On Feb. 2, 2021, ASTHO members and public health leaders Jill Hunsaker Ryan, MPH of Colorado, Ngozi Ezike, MD of Illinois, and Joneigh Khaldun of Michigan testified before a House subcommittee. Each panelist responded to questions from ...

On Feb. 2, 2021 ASTHO and the assembly of members pledged to ensure equitable access of the COVID-19 vaccine and to collect accurate demographic data to assure detection and response to any potential disparities in vaccine administration.

On Oct. 13, 2022, ASTHO CMO Marcus Plescia released a statement supporting ACIP's decision to encourage adding COVID-19 vaccinations to standard immunization schedules.

On April 7, 2022 ASTHO unveiled "Sustained Management of COVID-19: Considerations for State and Territorial Health Agencies," a set of actionable, evidence-based strategies for state and territorial public health agencies to ...

On May 15, 2020, ASTHO and National Coalition of STD Directors announced that their joint training program, Making Contact, has trained over 10,000 individuals across the country in entry-level COVID-19 contact tracing.